Cihan Ay and Colleagues on Thromboembolism and Bleeding in Multiple Myeloma
RPTH Journal shared on LinkedIn:
”In newly diagnosed multiple myeloma patients on immunomodulatory drugs, VTE and bleeding risks remain high.
Direct oral anticoagulants showed a trend toward lower VTE vs aspirin/no prophylaxis, but bleeding rates were similar across all strategies.
Check out the full article for more details.”
Read the full article in RPTH.
Article: Thromboembolism and bleeding in newly diagnosed multiple myeloma: rates, risk profile, and patterns of thromboprophylaxis
Authors: Lea Vospernik, Hermine Agis, Cihan Ay, Lina Rüsing, Heinz Gisslinger, Christina Brunbauer, Clara Sophie Michel, Ingrid Simonitsch-Klupp, Alexandra Kaider, Maria-Theresa Krauth, Julia Riedl
Stay updated on all scientific advances in the field of clotting disorders with Hemostasis Today.
-
May 23, 2026, 05:38SIUH Advances Precision Stroke Care with Vena MicroAngioscope – Northwell Health
-
May 23, 2026, 05:31Kalyan Roy: Precision Blood Matching in Transfusion-Dependent Thalassaemia
-
May 23, 2026, 05:29Understanding Hepatitis A, B, and C During Hepatitis Awareness Month – UNC Health
-
May 23, 2026, 03:55WFH Initiative Brings Hope to the Hemophilia Community in India
-
May 23, 2026, 03:47Satyam Arora: Welcoming the New ISBT Board for the 2026 Term
-
May 23, 2026, 03:33Brig Tathagata Chatterjee: Connecting With World Leaders in Hematology at ISH Congress
-
May 23, 2026, 03:18Mathangi Kumar: Dental Management Strategies for Congenital Hemophilia
-
May 23, 2026, 03:02Maitri Vaishnav: Anatomical Variability and Surgical Relevance of Corona Mortis
-
May 23, 2026, 02:26Muhammad Hashim: When the Blood Smear Told a Different Story Behind a ‘Critical’ Platelet Count